Jeena Sikho Lifecare Share Price Today | Stock Price & Jeena Sikho Lifecare Share Screener
As of October 5, 2026, the live Jeena Sikho Lifecare share price (NSE: JSLL) is ₹449.90 on NSE and ₹449.80 on BSE, down 6.43% from the previous close, with shares trading between ₹445.65 and ₹486.25 in today's trading session, and a 52-week range of ₹449.90–₹794.00. Check JSLL annual price range for the annual price range and momentum. Use the Jeena Sikho Lifecare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Jeena Sikho Lifecare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹219 and net income of ₹45, with EBITDA of ₹81, an operating margin of 36.0% and a profit margin of 20.6%.
Jeena Sikho Lifecare Share Price Chart
Track the current stock price of Jeena Sikho Lifecare with an interactive chart. Analyse JSLL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Jeena Sikho Lifecare stock quote in one place.
The quote of ₹449.90 sits between the 52-week low of ₹449.90 and the 52-week high of ₹794.00, and the latest session moved -6.43% from the previous close.
Jeena Sikho Lifecare Company Profile - Fundamental Screener
Screen Jeena Sikho Lifecare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JSLL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0J5801029.
Company Details
Classification
Identifiers and Leadership
Jeena Sikho Lifecare Balance Sheet Screener
Screen JSLL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹674, up from ₹419 in 2025.
Latest statistics put total assets at ₹674 and shareholder funds at ₹467, with a leverage ratio of 0.34.
| Item | 2026 | 2025 | 2023 | 2022 |
|---|---|---|---|---|
Assets |
||||
| Total Assets | 674 | 419 | 151 | 62 |
| Current Assets | 341 | 135 | 78 | 22 |
| Fixed Assets | 293 | 253 | 60 | 29 |
Liabilities |
||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 102 | 89 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||
| Total Equity | 467 | 256 | 126 | 37 |
| Share Capital | 25 | 25 | 14 | 10 |
| Reserves & Surplus | 442 | 232 | 112 | 26 |
Jeena Sikho Lifecare Income Statement Screener - Profit & Revenue Analysis
Screen Jeena Sikho Lifecare income statement and profit fundamentals. Analyze JSLL quarterly results. Jeena Sikho Lifecare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹219 and net profit was ₹45, equal to earnings per unit of ₹3.63, at an operating margin of 36%.
In that period expenses were ₹138, interest cost ₹4 and tax ₹16. The next period listed, 2026-Jun, shows revenue of ₹239 and net profit of ₹66.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||
| Revenue | 219 | 239 | 140 | 175 | 191 | 224 | 103 | 118 | 116 |
| Expenses | 138 | 132 | 94 | 96 | 98 | 121 | 75 | 74 | 86 |
Operating Costs and Margins | |||||||||
| EBITDA | 81 | 106 | 46 | 80 | 94 | 103 | 28 | 44 | 30 |
| Operating Profit % | 36.00% | 41.00% | 33.00% | 45.00% | 48.00% | 45.00% | 25.00% | 35.00% | 26.00% |
| Depreciation | 16 | 15 | 9 | 10 | 10 | 11 | 5 | 6 | 9 |
| Interest | 4 | 4 | 3 | 2 | 4 | 3 | 2 | 2 | 4 |
Profit and Earnings | |||||||||
| Profit Before Tax | 61 | 88 | 34 | 69 | 79 | 89 | 21 | 35 | 18 |
| Tax | 16 | 22 | 9 | 17 | 20 | 22 | 5 | 9 | 5 |
| Net Profit | 45 | 66 | 25 | 51 | 59 | 67 | 16 | 27 | 13 |
| EPS | 3.63 | 5.30 | 2.04 | 4.12 | 4.73 | 5.36 | 1.27 | 2.14 | 1.06 |
Jeena Sikho Lifecare Cash Flow Screener - Liquidity Fundamentals
Screen JSLL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹254, and net cash flow was an outflow of ₹7.
Over the same period, investing activities used ₹202 and financing activities used ₹59.
| Item | 2026-March | 2025-March | 2023-March | 2022-March |
|---|---|---|---|---|
Cash from Operations and Investing | ||||
| Operating Activities | 254 | 85 | 15 | 16 |
| Investing Activities | -202 | -64 | -33 | -19 |
Financing and Net Cash | ||||
| Financing Activities | -59 | -23 | 48 | -5 |
| Net Cash Flow | -7 | -2 | 29 | -7 |
Jeena Sikho Lifecare Shareholding Pattern Screener
See Jeena Sikho Lifecare shareholding pattern with promoter, FII, and DII holdings. Check Jeena Sikho Lifecare promoter holding and ownership changes for JSLL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 63.62%, foreign institutions 6.17%, domestic institutions 0.46% and the public 18.37%, spread across 25,905 shareholders.
The shareholder count was 25,905 in 2026-Mar, compared with 43,413 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Aug | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 63.62% | 63.62% | 63.53% | 63.53% | 63.53% | 63.61% | 63.62% | 67.91% |
Institutional Investors | ||||||||
| FII Holding | 6.17% | 4.78% | 0.00% | 0.00% | 5.99% | 6.59% | 6.31% | 0.00% |
| DII Holding | 0.46% | 0.36% | 0.00% | 0.00% | 0.18% | 0.15% | 0.11% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.37% | 21.02% | 16.67% | 17.05% | 17.20% | 17.32% | 18.19% | 17.34% |
| Other Holding | 11.38% | 10.22% | 19.80% | 19.41% | 13.10% | 12.33% | 11.76% | 14.75% |
| Shareholder Count | 25,905 | 43,413 | 5,967 | 6,603 | 7,434 | 16,362 | 22,181 | 2,721 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Jeena Sikho Lifecare. Jeena Sikho Lifecare dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹4.50 per unit for 2026-March, a yield of 0.90%, compared with ₹5.47 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹4.50, ₹5.47 and ₹4.80 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹4.50 | 0.90% |
| 2025-March | ₹5.47 | 1.01% |
| 2024-March | ₹4.80 | 1.10% |
| 2023-March | ₹2.00 | 1.19% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Jeena Sikho Lifecare Stock Index Membership - Nifty & Sensex
See which indices include Jeena Sikho Lifecare stock. Check JSLL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Jeena Sikho Lifecare Market Events Screener - Corporate Actions
Get Jeena Sikho Lifecare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Jeena Sikho Lifecare stock events that may affect JSLL share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 28, 2026, with a record date of September 28, 2026.
It is followed by Dividend dated September 21, 2026 and Quarterly Result Announcement dated August 7, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-28 | 2026-09-28 | Annual General Meeting | NA | -0.55% |
| 2026-09-21 | 2026-09-21 | Dividend | ₹ 4.50 /share | -17.12% |
| 2026-08-07 | 2026-08-07 | Quarterly Result Announcement | NA | 3.74% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -5.34% |
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | 9.83% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | 5.14% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 14.86% |
| 2025-09-22 | 2025-09-22 | Dividend | ₹ 1.10 /share | 73.71% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 2.44% |
| 2025-06-12 | 2025-06-12 | Split | 2:10 | -0.01% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 3.04% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | -0.97% |
| 2024-08-28 | 2024-08-28 | Annual General Meeting | NA | 17.80% |
| 2024-08-20 | 2024-08-20 | Dividend | ₹ 4.18 /share | 26.31% |
| 2024-02-27 | 2024-02-27 | Extraordinary General Meeting | NA | 33.82% |
Jeena Sikho Lifecare Competitors Screener - Peer Stocks Comparison
Screen JSLL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,476 | 36.44 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 250,363 | 86.51 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 186,152 | 85.91 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 120,798 | 26.32 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 111,426 | 33.44 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,838 | 99.70 | 6,868 | 22.01% | 890 | 58.00 |
| Mankind Pharma | 105,107 | 48.73 | 14,636 | 14.85% | 1,938 | 64.24 |
| Dr Reddys Laboratories | 104,492 | 32.05 | 35,059 | 3.90% | 4,158 | 69.59 |
| Aurobindo Pharma | 97,682 | 26.36 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,829 | 16.99 | 29,039 | 26.75% | 5,356 | 34.02 |
Jeena Sikho Lifecare Company Announcements - News & Reports Screener
Screen JSLL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated and October 5, 2026.
| Date | Update | Actions |
|---|---|---|
| Disclosure Under Regulation 29(2) Of The Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | - | |
| Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - | |
| 2026-10-05 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-10-02 | Closure of Trading Window | - |
| 2026-09-30 | Intimation Of In-Principle Approval Received From BSE Limited For Listing Of Up To A Maximum Of 650000 Equity Shares Of Rs. 2/-Each Of Jeena Sikho Lifecare Limited To Be Issued Under Jeena Sikho Employees Stock Option Scheme 2024 (ESOS 2024). | - |
| 2026-09-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-28 | Intimation For Launch Of New Products | - |
| 2026-09-09 | Intimation Regarding Postponement In Commencement Of Commercial Operations At The New Hospital Facility In Lucknow Uttar Pradesh | - |
| 2026-09-09 | Intimation Regarding Postponement In Commencement Of Commercial Operations At The New Day Care Clinic In Ayodhya Uttar Pradesh | - |
| 2026-09-08 | Receipt Of NABH Accreditation For Pune Hospital | - |
| 2026-09-05 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Launch Of New Product | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-04 | The Aforesaid Communication Provides The Web-Link Through Which The Integrated Annual Report Of The Company For The Financial Year 2025-26 And The Notice Convening The 9Th Annual General Meeting Of The Company Can Be Accessed On The CompanyS Website | - |
| 2026-09-04 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Notice Of The 9Th Annual General Meeting And Integrated Annual Report For Financial Year 2025-26 | - |
| 2026-09-02 | Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Launch Of New Products | - |
| 2026-08-31 | Fixation Of Date Of AGM | - |
| 2026-08-31 | Announcement under Regulation 30 (LODR)-Dividend Updates | - |
| 2026-08-31 | Fixation Of Dividend Record Date | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹449.90, within a 52-week range of ₹449.90 to ₹794.00. The P/E ratio is 26.43 and the P/B ratio is 13.37, with earnings per unit of ₹17.84. Market capitalisation stands at ₹6,332.50 Cr and the dividend yield is 0.90%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 4 balance sheet periods, 9 income statement periods, 4 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.